This is what analysts have to say about CVS Health Corporation (NYSE:CVS) after last week.

CVS Health Corporation (NYSE:CVS) Logo
Investors sentiment increased to 1.89 in 2018 Q4. Its up 0.77, from 1.12 in 2018Q3. It improved, as 60 investors sold CVS Health Corporation shares while 362 reduced holdings. 200 funds opened positions while 596 raised stakes. 1.03 billion shares or 24.58% more from 828.14 million shares in 2018Q3 were reported.
Eagleclaw Managment Ltd Com, a Massachusetts-based fund reported 33,613 shares. Argent Trust Commerce owns 59,107 shares. Old Second Retail Bank Of Aurora invested in 56,802 shares or 1.51% of the stock. Mcf Advisors Lc has invested 0.01% in CVS Health Corporation (NYSE:CVS). Gam Holding Ag holds 0.2% of its portfolio in CVS Health Corporation (NYSE:CVS) for 59,334 shares. Loring Wolcott & Coolidge Fiduciary Advsr Limited Liability Partnership Ma has 349,972 shares. Hennessy Advsrs Incorporated holds 0.36% or 110,400 shares. Tarbox Family Office stated it has 627 shares. Edgar Lomax Va reported 888,433 shares. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment Mgmt Corp holds 568,489 shares. Strs Ohio has 804,898 shares for 0.27% of their portfolio. Boyar Asset holds 0.6% in CVS Health Corporation (NYSE:CVS) or 11,035 shares. Chesley Taft & Assoc Limited Liability Corporation invested 0.66% in CVS Health Corporation (NYSE:CVS). Finemark Retail Bank And Trust reported 9,578 shares. First Trust Advisors Limited Partnership reported 519,348 shares.

Since November 14, 2018, it had 6 insider purchases, and 3 sales for $22.56 million activity. MERLO LARRY J sold $10.73M worth of CVS Health Corporation (NYSE:CVS) on Friday, February 1. 2,000 shares valued at $105,600 were bought by LUDWIG EDWARD J on Friday, March 8. 10,000 CVS Health Corporation (NYSE:CVS) shares with value of $531,800 were bought by BROWN C DAVID II. Brennan Troyen A sold $1.17M worth of stock. 25,159 shares were sold by Denton David M, worth $2.02 million on Thursday, November 29. DORMAN DAVID W bought $506,016 worth of stock or 9,600 shares.

CVS Health Corporation (NYSE:CVS) Ratings Coverage

Among 18 analysts covering CVS Health (NYSE:CVS), 15 have Buy rating, 0 Sell and 3 Hold. Therefore 83% are positive. CVS Health had 34 analyst reports since November 26, 2018 according to SRatingsIntel. The stock has “Buy” rating by SunTrust on Thursday, February 21. Argus Research maintained it with “Buy” rating and $80 target in Monday, February 25 report. Mizuho maintained the stock with “Buy” rating in Wednesday, February 20 report. Robert W. Baird maintained CVS Health Corporation (NYSE:CVS) on Thursday, February 21 with “Hold” rating. As per Wednesday, February 20, the company rating was downgraded by Wells Fargo. Mizuho maintained it with “Buy” rating and $71 target in Wednesday, February 27 report. The rating was maintained by Barclays Capital on Monday, February 25 with “Buy”. The firm earned “Buy” rating on Thursday, February 14 by Cantor Fitzgerald. The firm earned “Buy” rating on Thursday, February 21 by J.P. Morgan. The stock has “Buy” rating by J.P. Morgan on Wednesday, November 28. Below is a list of CVS Health Corporation (NYSE:CVS) latest ratings and price target changes.

02/05/2019 Broker: UBS Old Rating: Buy New Rating: Buy Old Target: $74.0000 New Target: $67.0000 Maintain
02/05/2019 Broker: BidaskScore Rating: Hold Upgrade
29/04/2019 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $92.0000 New Target: $74.0000 Maintain
18/04/2019 Broker: Raymond James Old Rating: Strong Buy New Rating: Strong Buy Old Target: $90 New Target: $75 Maintain
18/04/2019 Broker: Guggenheim Rating: Buy Initiates Coverage On
15/04/2019 Broker: Oppenheimer Old Rating: Outperform New Rating: Perform Downgrade
11/04/2019 Broker: BMO Capital Markets Rating: Outperform New Target: $58 Initiates Coverage On
02/04/2019 Broker: BidaskScore Rating: Sell Downgrade
16/03/2019 Broker: BidaskScore Rating: Hold Upgrade
15/03/2019 Broker: Cowen & Co Rating: Buy New Target: $69 Maintain

The stock increased 1.11% or $0.58 during the last trading session, reaching $52.88. About 7.93 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 16.66% since May 17, 2018 and is downtrending. It has underperformed by 21.03% the S&P500.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. The company has market cap of $68.70 billion. It operates through Pharmacy Services and Retail/LTC divisions. It currently has negative earnings. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: which released: “CVS Health Q1 2019 Earnings Preview – Seeking Alpha” on April 30, 2019, also with their article: “Investor Ideas Potcasts, Cannabis News and Stocks on the Move May 10th (CSE: ABCS) (NYSE: CVS) (CSE: CURA) (TSXV: VIVO) –” published on May 10, 2019, published: “CVS Health to close 46 stores, including 4 Florida locations – Orlando Business Journal” on May 02, 2019. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: and their article: “Earnings Scheduled For May 1, 2019 – Benzinga” published on May 01, 2019 as well as‘s news article titled: “It’s a Little Dicey, but CVS Stock Actually Might Have Turned the Corner –” with publication date: April 29, 2019.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.